Actinium Pharmaceuticals, Inc. (ATNM)
Net Income Growth
127.56%
TTM · Period ending:
ATNM Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported127.56%period ending
Latest reported127.56%period ending
ATNM TTM Net Income YoY % (-42.26% → 127.56%)
Year-over-year change
High-resolution chart · PNG
ATNM net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 127.5563% | |
| 48.4279% | |
| 11.3903% | |
| 15.4369% | |
| 3.7233% | |
| 2.0236% | |
| 21.6621% | |
| 18.4001% | |
| 8.0192% | |
| -19.3346% | |
| -47.8572% | |
| -65.0461% | |
| -69.5598% | |
| -58.3411% | |
| -33.2728% | |
| -31.2651% | |
| -22.7663% | |
| -12.4308% | |
| -11.5192% | |
| -13.2432% | |
| -3.5567% | |
| 0.1527% | |
| -1.4456% | |
| 13.4594% | |
| 7.203% | |
| 4.7936% | |
| 7.3866% | |
| -5.016% | |
| -2.2151% | |
| 7.4555% | |
| 11.1157% | |
| 20.0711% | |
| 20.2316% | |
| 11.1754% | |
| -9.3742% | |
| -16.4191% | |
| -32.0582% | |
| -25.1722% | |
| -15.6758% | |
| -21.3751% | |
| 2.3954% | |
| -102.0609% | |
| 14.8297% | |
| 20.8027% | |
| -7.6007% | |
| 58.6955% | |
| -129.135% | |
| -89.9441% | |
| -38.1601% | |
| -96.8543% | |
| 22.0738% | |
| -141.2442% | |
| -498.3285% | |
| -1,420.8777% | |
| -134,475.6342% | |
| -124,398.9579% | |
| -141,423.1296% | |
| -15,097.7368% | |
| 514.6356% | |
| 531.4735% | |
| -126.8188% | |
| 123.564% | |
| 107.4963% | |
| 103.4188% | |
| 132.7646% | |
| 1.6091% | |
| 28.5248% | |
| 27.6709% | |
| 36.3172% | |
| -2.1236% | |
| -111.1014% | |
| -52.495% | |
| -42.2577% |